OTC Markets OTCPK - Delayed Quote USD

RHÖN-KLINIKUM Aktiengesellschaft (RKAGY)

7.85
0.00
(0.00%)
At close: May 12 at 4:00:00 PM EDT
Loading Chart for RKAGY
  • Previous Close 0.00
  • Open 9.03
  • Bid 7.17 x 40000
  • Ask 8.16 x 40000
  • Day's Range 8.93 - 9.07
  • 52 Week Range 6.05 - 9.07
  • Volume 426
  • Avg. Volume 20
  • Market Cap (intraday) 1.051B
  • Beta (5Y Monthly) 0.02
  • PE Ratio (TTM) 23.09
  • EPS (TTM) 0.34
  • Earnings Date Aug 7, 2025
  • Forward Dividend & Yield 0.05 (0.70%)
  • Ex-Dividend Date Jun 5, 2025
  • 1y Target Est --

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. It also operates acute hospitals, medical care centers, and rehabilitation hospitals. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

www.rhoen-klinikum-ag.com

18,819

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RKAGY

View More

Performance Overview: RKAGY

Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

RKAGY
29.75%
DAX P (^GDAXI)
18.46%

1-Year Return

RKAGY
29.75%
DAX P (^GDAXI)
25.83%

3-Year Return

RKAGY
8.67%
DAX P (^GDAXI)
68.12%

5-Year Return

RKAGY
17.88%
DAX P (^GDAXI)
123.70%

Compare To: RKAGY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RKAGY

View More

Valuation Measures

Annual
As of 5/12/2025
  • Market Cap

    1.04B

  • Enterprise Value

    733.67M

  • Trailing P/E

    23.26

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.57

  • Price/Book (mrq)

    0.72

  • Enterprise Value/Revenue

    0.40

  • Enterprise Value/EBITDA

    5.56

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.10%

  • Return on Assets (ttm)

    1.53%

  • Return on Equity (ttm)

    3.16%

  • Revenue (ttm)

    1.89B

  • Net Income Avi to Common (ttm)

    39.69M

  • Diluted EPS (ttm)

    0.34

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    262.81M

  • Total Debt/Equity (mrq)

    11.26%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: RKAGY

View More

Company Insights: RKAGY

Research Reports: RKAGY

View More

People Also Watch